A Study on Kalanjagapadai (Psoriasis)

Murugavel, T (2018) A Study on Kalanjagapadai (Psoriasis). Masters thesis, Government Siddha Medical College, Palayamkottai.


Download (33MB) | Preview


The disease psoriasis was reasonably studied with the disease KALANJAGA PADAI with reference to its causes. Pathogenesis and clinical features. The aim of this study is to treat the illness and sufferings of Psoriasis. psoriasis is a common and distressing skin condition. Importantly, it is not simply a cosmetic problem- even people with limited disease find the condition affect their everyday lives (stern Rs.et.al. 2004-9(2) 136-39). The trial medicines are prepared as per siddha literature. The trial medicines were; 1. OMA LEGIYAM 5.1g (B.d), 2. THAGARAI LEBAM (external). The trial drug was given to 40 patients, for 48 days. The patients was selected based on inclusion and exclusion criteria. While starting the treatment routine blood analysis, urine analysis, kidney function test and liver function test were done. Siddha methods like udal thathukkal, Envagai thervu, Neerkuri and Neikuri were noted in case sheet proforma. Patients were instructed to come for next review once in 7 days. Age: Most of the patients are from the age group (41-50). Thinai: Most of the patients were from marutham thinai. Occupation: The Coolie workers are mostly affected by Psoriasis. Stress is also a major triggering factor for Psoriasis. Diet and Physical habits: Most of the patients were non vegetarians and smoke may also have a major impact on Psoriasis. Udal kattugal: From the seven udal kattugal, saaram, seneer have been affected in all of the 40 cases enbu and kozhuppu have been affected 12.5% of cases. Pre clinical studies: The pharmacological analysis of OMA LEGIYAM shows that these medicines have 1. Anti inflammatory effect, 2. Anti histaminic effect. Result the clinical outcome was assessed by gradations. Hence the result shows that 67.5% had good improvement. Particularly the results were marvelous when it is given trial drug along with complement therapies. CONCLUSION: KALANJAGAPADAI (PSORIASIS) is primarly due the derangement of vadham. The trial medicine “OMA LEGIYAM” predominates with kaippu taste respectively neutralizes the vatham. Preclinical studies shows that these medicines have anti inflammatory and anti histamine, effect and moderate analgesic effect. The “OMA LEGIYAM do not produce any toxicity in preclinical study. So it is not toxic and safe drug for psoriasis. No contraindications were reported during the course of treatment. The overall outcome of this disease is astounding. The clinical signs in this study were found to have 67.5% good improvement. When trial medicines are given along with complement therapy were found to have wonderful effect compared to giving trial medicines alone. Therefore the author concluded that the trial medicine “OMA LEGIYAM” is very positive remedy for “Kalanjagapadai”.

Item Type: Thesis (Masters)
Additional Information: (Reg.No.321513006)
Uncontrolled Keywords: Kalanjagapadai ; Psoriasis ; Oma Legiyam ; Thagarai Lebam.
Subjects: AYUSH > Sirappu Maruthuvam
Depositing User: Subramani R
Date Deposited: 29 Dec 2018 11:24
Last Modified: 29 Dec 2018 11:24
URI: http://repository-tnmgrmu.ac.in/id/eprint/10247

Actions (login required)

View Item View Item